化合物 T10594
| 中文名称 | 化合物 T10594 |
|---|---|
| 中文同义词 | 化合物 T10594;BISPEROXO(1,10-菲咯啉)氧钒酸钾(V)三水合物;化合物 BPV(PHEN) |
| 英文名称 | BPV(PHEN) |
| 英文同义词 | POTASSIUM BISPEROXO(1,10-PHENANTHROLINE)OXOVANADATE (V);BPV(PHEN);K[VO(O2)2C12H8N2] 3H2O;Potassium Bisperoxo(1,10-phenanthroline)oxovanadate (V) trihydrate;bpV(phen) - CAS 42494-73-5 - Calbiochem |
| CAS号 | 42494-73-5 |
| 分子式 | C12H8KN2O5V |
| 分子量 | 350.24 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 42494-73-5.mol |
| 结构式 |  |
化合物 T10594 性质
| 储存条件 | -20°C |
|---|---|
| 溶解度 | 在水中的溶解度为20mg/mL，澄清 |
| 形态 | 黄色固体 |
| 颜色 | 淡黄色至深黄色 |
IC50: 38 nM (PTEN), 343 nM (PTP-β) and 920 nM (PTP-1B)
Parasite
Leishmania
Apoptosis
bpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment causes a further decrease of cell viability in H/R-injured H9c2 cells.
bpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment increases the apoptosis of H/R-injured H9c2 cells.
bpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment significantly promotes the accumulation of cytoplasmic Cytochrome C in H/R-injured H9c2 cells.
After stimulation of bpV(phen), PTEN-induced putative kinase protein 1 (PINK1)/Parkin-mediated mitophagy is inhibited.
bpV(phen) is an insulin-mimetic agent following insulin-receptor tyrosine kinase hyperphosphorylation and activation.
Cell Viability Assay
| Cell Line: | Hypoxia/reoxygenation (H/R)-injured H9c2 cells |
| Concentration: | 5 μM |
| Incubation Time: | 24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes) |
| Result: | Caused a further decrease of cell viability. |
Apoptosis Analysis
| Cell Line: | Hypoxia/reoxygenation (H/R)-injured H9c2 cells |
| Concentration: | 5 μM |
| Incubation Time: | 24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes) |
| Result: | Increased the apoptosis of H/R-injured H9c2 cells. |
Western Blot Analysis
| Cell Line: | Hypoxia/reoxygenation (H/R)-injured H9c2 cells |
| Concentration: | 5 μM |
| Incubation Time: | 24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes) |
| Result: | Showed an increased release of Cytochrome C. |
bpV(phen) (5 mg/kg; intraperitoneal injection; daily; for 38 days; male BALB/c nude (nu/nu) athymic mice) treatment causes a significant reduction in average tumor volume.
| Animal Model: | Male BALB/c nude (nu/nu) athymic mice (6-7 weeks old) injected with PC-3 cells |
| Dosage: | 5 mg/kg |
| Administration: | Intraperitoneal injection; daily; for 38 days |
| Result: | Caused a significant reduction in average tumor volume. |